NASDAQ NMS - GLOBAL MARKET · INBS
-0.40% · -$0.0100 · Vol Not reported
Pre-market · updated 04:11:01 ET
Intelligent Bio Solutions Inc

Intelligent Bio Solutions Inc

Health Care
$2.50
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
INBS
Intelligent Bio Solutions Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is INBS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading INBS catalysts
About Intelligent Bio Solutions Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2020
Employees
60
Country
US

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.51
Last session
Day high
$2.51
Last session
Day low
$2.51
Last session
Previous close
$2.51
52W high
$18.80
-86.70% from high
52W low
$1.55
6% of range
Market cap
$7.6M
EPS
$-5.4100
Beta
0.70
Shares out
3M
Avg volume
114.9K
VWAP
$2.51
Last session
Price history computed in-house
1W
-25.82%
1M
+42.86%
3M
-5.66%
1Y
-83.11%
YTD
-73.77%
SMA 50 $2.20 · above
SMA 200 $4.67 · below
52W position 6%

INBS overview

Loading financial statements
Loading INBS Form 4 filings
Public disclosures

Congress activity in INBS

No receipt-qualified Congressional disclosure is present for INBS in the cached public ledger.

Federal contracts

INBS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INBS in this window.
Lobbying spend

INBS lobbying filings, year to date.

Registered lobbying filings matched to Intelligent Bio Solutions Inc.

$2.0M
Refresh interval: 12hSource: LDA disclosure filings
Budget/Appropriations Manufacturing Science/Technology Taxation/Internal Revenue Code Foreign Relations Environment/Superfund Trade (domestic/foreign) Education Economics/Economic Development Government Issues Defense Telecommunications Labor Issues/Antitrust/Workplace Immigration Copyright/Patent/TrademarkBudget/Appropriations Defense Manufacturing Science/Technology Trade (domestic/foreign)Budget/Appropriations Defense Manufacturing Science/Technology Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
Filing
$700.0K
INTEL CORPORATION

INTEL CORPORATION

Jul 17, 2026
Filing
$680.0K
INTEL CORPORATION

INTEL CORPORATION

Apr 20, 2026
Filing
$490.0K
INTEL CORPORATION

INTEL CORPORATION

Jan 20, 2026
Loading news for INBS
Analyst ratings
Sovereign unlock shows live analyst consensus for INBS.
Options
Sovereign unlock shows live options positioning for INBS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.